Acta Med. 1998, 41: 19-21
https://doi.org/10.14712/18059694.2019.162
A Comparison of the Therapeutic Efficacy of Conventional and Modern Oximes Against Supralethal Doses of Highly Toxic Organophosphates in Mice
References
1. J. Biological monitoring of exposure to nerve agent. Br J Ind Med 1992; 49:648-53.
2. J. Present views on toxidynamics of soman poisoning. Acta Med (Hradec Králové), 1996; 39:101-5.
3. J, Kassa J, Elsnerová I, Dejmek L. Cholinesterase reactivators derived from pyridine-2-carbaldoxime. Collect Czech Chem Commun 1998; 63:199-204.
<https://doi.org/10.1135/cccc19980199>
4. H-Ch, Bai D-Y, Jiang Y-P. Effects of HI-6 on muscle acetylcholine receptor: analysis on minimal reaction model. Acta Pharmacol Sin 1996; 17:428-31.
5. RM. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 1994; 14:317-31.
<https://doi.org/10.1002/jat.2550140502>
6. LPA, Verhagen MAA, Langenberg JP, Hagedorn I, Löffler M. The bispyridinium-dioxime HLö-7, a potent reactivator for acetylcholinesterase inhibited by the stereoisomers of tabun and soman. Biochem Pharmacol 1989; 38:633-40.
<https://doi.org/10.1016/0006-2952(89)90209-8>
7. P, Ladstetter B, Schofer W, Sonnenbichler J. Studies on the stability and decomposition of the hagedorn oxime HLö-7 in aquaeous solution. Arch Toxicol 1989; 63:59-67.
<https://doi.org/10.1007/BF00334636>
8. P, Hagedorn I, Klimmek R, Lippstreu P, Löffler M, Oldiges H, Spöhrer U, Steidl J, Szinicz L, Worek F. HLö-7 dimethansulfonate, a potent bispyridinium-dioxime against anticholinesterases. Arch Toxicol 1992; 66:603-21.
<https://doi.org/10.1007/BF01981499>
9. J. Comparison of efficacy of two oximes (HI-6 and obidoxime) in soman poisoning in rats. Toxicology 1995; 101:167-74.
<https://doi.org/10.1016/0300-483X(95)03091-S>
10. J., Cabal J, Bajgar J, Szinicz L. The choice: HI-6, pralidoxime or obidoxime against nerve agents? ASA Newslett 1997; 97-4:16-18.
11. I, Stewart JR. A comparison of the efficacy of HI-6 and 2-PAM against soman, tabun, sarin and VX in the rabbit. Toxicol Lett 1994; 70:269-79.
<https://doi.org/10.1016/0378-4274(94)90121-X>
12. E, Cid HMB, Holzgrabe U, Mohr K. Evidence for a multiple binding mode of bispyridinium-type allosteric modulators of muscarinic receptors. Eur J Pharmacol 1996; 314:385-92.
<https://doi.org/10.1016/S0014-2999(96)00568-7>
13. TC. Organophosphate poisoning. Pharmacol Ther 1993; 58:51-66.
<https://doi.org/10.1016/0163-7258(93)90066-M>
14. CG, Dua AK. Pharmacology of HI-6, an Hseries oxime. Can J Physiol Pharmacol 1989; 67:1183-9.
<https://doi.org/10.1139/y89-188>
15. T-M, Whalley ChE, Valdes JJ. A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2- PAM) in soman poisoning. Toxicol Lett 1991; 55:131-47.
16. T-M. Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats. Arch Toxicol 1993; 67:637-46.
<https://doi.org/10.1007/BF01974071>
17. Tallarida R, Murray R. Manual of pharmacological calculation with computer programs. Springer-Verlag, New York 1987;p. 145.
18. JEH. Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro. Br J Pharmacol 1993; 108:1006-15.
<https://doi.org/10.1111/j.1476-5381.1993.tb13498.x>
<PubMed>
19. HPM, Busker RW, Melchers BPC, Bruijnzeel PLB. Pharmacological effects of oximes: how relevant are they? Arch Toxicol 1996; 70:779-86.
<https://doi.org/10.1007/s002040050340>
